1. A national case–control study investigating demographic and environmental factors associated with NMOSD. (April 2023) Authors: Rotstein, Dalia L; Wolfson, Christina; Carruthers, Robert; Freedman, Mark S; Morrow, Sarah A; Lee, Liesly; Burton, Jodie M; Nisenbaum, Rosane; Konig, Andrea; Magalhaes, Sandra; Marrie, Ruth Ann Journal: Multiple sclerosis Issue: Volume 29:Number 4/5(2023) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A protean disease: The phenotypic range of neuromyelitis optica spectrum disorder. (April 2018) Authors: Rotstein, Dalia L Journal: Multiple sclerosis Issue: Volume 24:Number 5(2018) Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: No. (September 2022) Authors: Rotstein, Dalia L Journal: Multiple sclerosis Issue: Volume 28:Number 10(2022) Page Start: 1500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. (September 2014) Authors: Carruthers, Robert L; Rotstein, Dalia L; Healy, Brian C; Chitnis, Tanuja; Weiner, Howard L; Buckle, Guy J Journal: Multiple sclerosis Issue: Volume 20:Number 10(2014) Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases. (August 2020) Authors: Rotstein, Dalia L; Sawicka, Katherine; Bharatha, Aditya; Montalban, Xavier; Lipton, Jeffrey H Journal: Multiple sclerosis Issue: Volume 26:Number 9(2020) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diet quality and risk of multiple sclerosis in two cohorts of US women. (November 2019) Authors: Rotstein, Dalia L; Cortese, Marianna; Fung, Teresa T; Chitnis, Tanuja; Ascherio, Alberto; Munger, Kassandra L Journal: Multiple sclerosis Issue: Volume 25:Number 13(2019) Page Start: 1773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disease-modifying therapies should be stopped in NMOSD patients in remission – No. (August 2019) Authors: Rotstein, Dalia L Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSD. (April 2022) Authors: Rotstein, Dalia L Journal: Multiple sclerosis Issue: Volume 28:Number 4(2022) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗